Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Ibrahim Al Jammaz"'
Autor:
Mai Al-Mohanna, Noura N. Alraouji, Samiah A. Alhabardi, Falah Al-Mohanna, Basem Al-Otaibi, Ibrahim Al-Jammaz, Abdelilah Aboussekhra
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract Anaplastic thyroid carcinoma (ATC) is the rarest type of thyroid cancer, but is the common cause of death from these tumors. The aggressive behavior of ATC makes it resistant to the conventional therapeutic approaches. Thus, the present stud
Externí odkaz:
https://doaj.org/article/3d1fa440d48a4abe8f5cf6125e6bb807
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract PAC (3,5-Bis (4-hydroxy-3-methoxybenzylidene)-N-methyl-4-piperidone), a novel bioactive curcumin analog, has been reported to have anticancer properties against various tumors. However, the anti-cancer effects of PAC on oral cavity squamous
Externí odkaz:
https://doaj.org/article/3d7e5b83d5154a1d9bedd6eb63fbd80f
Autor:
Subhani M. Okarvi, Ibrahim Al-Jammaz
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:372-383
Autor:
Yufei Shi, Futwan A. Al-Mohanna, Ali S. Alzahrani, Brian F. Meyer, Abdullah M. Assiri, Falah Almohanna, Khalid S.A. Khabar, Ibrahim Al-Jammaz, Monther Al-Alwan, Suhad Al-Yahya, Yousif H. Al-Malki, Huda A. BinEssa, Minjing Zou
Fig. S1. Up-regulation of thyroid hormone synthesis-related genes in the BVE-Ctnnb1null thyroid tumors. Data are expressed as fold changes between BVE-Ctnnb1null and BVE tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::043c3fc3e82e43654a919e52983983da
https://doi.org/10.1158/1535-7163.22521871.v1
https://doi.org/10.1158/1535-7163.22521871.v1
Autor:
Yufei Shi, Futwan A. Al-Mohanna, Ali S. Alzahrani, Brian F. Meyer, Abdullah M. Assiri, Falah Almohanna, Khalid S.A. Khabar, Ibrahim Al-Jammaz, Monther Al-Alwan, Suhad Al-Yahya, Yousif H. Al-Malki, Huda A. BinEssa, Minjing Zou
BRAFV600E mutation is the most frequent genetic alteration in papillary thyroid cancer (PTC). β-Catenin (Ctnnb1) is a key downstream component of canonical Wnt signaling pathway and is frequently overexpressed in PTC. BRAFV600E-driven tumors have be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::190cd776a9698e2d2e090166b68c8ccd
https://doi.org/10.1158/1535-7163.c.6543208
https://doi.org/10.1158/1535-7163.c.6543208
Autor:
Mai Al-Mohanna, Noura N. Alraouji, Samiah A. Alhabardi, Falah Al-Mohanna, Basem Al-Otaibi, Ibrahim Al-Jammaz, Abdelilah Aboussekhra
Anaplastic thyroid carcinoma (ATC) is the rarest type of thyroid cancer but is the common cause of death from these tumors. The aggressive behavior of ATC makes it resistant to the conventional therapeutic approaches. Thus, the present study was desi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbf1bd83a5055ddf5c96a11524323782
https://doi.org/10.21203/rs.3.rs-2160938/v1
https://doi.org/10.21203/rs.3.rs-2160938/v1
Autor:
Yufei Shi, Ibrahim Al-Jammaz, Minjing Zou, Yousif H. Al-Malki, Ali S. Alzahrani, Brian F. Meyer, Futwan Al-Mohanna, Khalid S.A. Khabar, Huda A BinEssa, Falah Al-Mohanna, Abdullah M. Assiri, Monther Al-Alwan, Suhad Al-Yahya
Publikováno v:
Molecular Cancer Therapeutics. 20:1603-1613
BRAFV600E mutation is the most frequent genetic alteration in papillary thyroid cancer (PTC). β-Catenin (Ctnnb1) is a key downstream component of canonical Wnt signaling pathway and is frequently overexpressed in PTC. BRAFV600E-driven tumors have be
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Scientific Reports
Scientific Reports
PAC (3,5-Bis (4-hydroxy-3-methoxybenzylidene)-N-methyl-4-piperidone), a novel bioactive curcumin analog, has been reported to have anticancer properties against various tumors. However, the anti-cancer effects of PAC on oral cavity squamous cell carc
Publikováno v:
Journal of Chemistry, Vol 2014 (2014)
In an attempt to develop new tumor imaging radiotracers with favorable biochemical properties, we have synthesized new 68Ga-2-acetylpyridine semicarbazone (68Ga-[APSC]2) as a potential positron emission tomography (PET) tumor imaging agent using a st
Externí odkaz:
https://doaj.org/article/0f8d2a3820384e26b22b88715ca81a3c
Autor:
Minjing, Zou, Huda A, BinEssa, Yousif H, Al-Malki, Suhad, Al-Yahya, Monther, Al-Alwan, Ibrahim, Al-Jammaz, Khalid S A, Khabar, Falah, Almohanna, Abdullah M, Assiri, Brian F, Meyer, Ali S, Alzahrani, Futwan A, Al-Mohanna, Yufei, Shi
Publikováno v:
Molecular cancer therapeutics. 20(9)